USRE38916EExpiredUtility
APC Antibodies
Est. expiryJan 16, 2011(expired)· nominal 20-yr term from priority
Inventors:Bert VogelsteinKenneth W. KinzlerHans AlbertsenRakesh AnandMary CarlsonJoanna GrodenPhilip John HedgeGeoff JoslynAlexander Fred MarkhamYusuka NakamuraAndrew ThilverisRaymond L. White
C12Q 2600/158C12Q 2600/112A01K 2217/05C12Q 1/68C07K 14/82C07K 14/47Y10S530/828C12Q 1/6827C12Q 1/6886C12Q 2600/172C12Q 2600/156
82
PatentIndex Score
54
Cited by
13
References
8
Claims
Abstract
A human gene termed APC is disclosed. Methods and kits are provided for assessing mutations of the APC gene in human tissues and body samples. APC mutations are found in familial adenomatous polyposis patients as well as in sporadic colorectal cancer patients. APC is expressed in most normal tissues. These results suggest that APC is a tumor suppressor.
Claims
exact text as granted — not AI-modified1. A preparation of antibodies which specifically binds to a human APC (adenomatous polyposis coli) protein having an amino acid sequence as shown in SEQ ID NO:1, 2, or 7, SEQ ID NO: 2 or 7 and does not specifically bind to other human proteins.
2. A preparation of antibodies which specifically binds to a human APC protein which is the product of a mutant allele found in tumor, wherein the antibodies do not specifically bind to other human proteins, and wherein the human APC protein is a mutant form of the amino acid sequence shown in SEQ ID NOS:2 and 7, and the mutant allele is a mutant form of the nucleotide sequence shown in SEQ ID NO:1.
3. The preparation of claim 2 wherein the mutant allele contains a mutation selected from the group consisting of mutations at codons 243, 279, 288, 301,331,413,437, 456, 500, 712, and 1338.
4. The preparation of claim 2 wherein the mutant allele contains a premature stop codon.
5. The preparation of claim 2 wherein the mutant allele contains a missense mutation.
6. The preparation of claim 2 wherein the mutant allele contains a frameshift mutation.
7. The preparation of claim 2 wherein the mutant allele contains a splice junction mutation.
8. The preparation of claim 2 wherein the mutant allele contains an insertion mutation.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.